Abstract
Purpose
To compare the pregnancy outcomes between four regimens of luteal phase support (LPS), including vaginal progesterone, oral dydrogesterone, combination of oral dydrogesterone and gonadotropin releasing hormone analog (GnRH-α), and combination of oral dydrogesterone and human chorionic gonadotrophin (hCG), in Frozen-thawed Embryo Transfer (FET) cycles.
Methods
This randomized clinical trial was performed during a 6-month period, including candidates for FET. Patients were randomly assigned to four groups for LPS: 400 mg vaginal progesterone suppository twice daily, 10 mg oral dydrogesterone twice daily, 10 mg oral dydrogesterone twice daily combined with injection of 0.1 mg GnRH-α, and 10 mg oral dydrogesterone twice daily combined with injection of 1500 IU hCG. Primary endpoint included clinical pregnancy rate, ongoing pregnancy rate (OPR), and miscarriage rate (MR).
Results
A total of 400 FET cycles were analyzed. CPR was significantly lower in dydrogesterone group (9 %) when compared to vaginal progesterone (20 %), dydrogesterone and GnRH-α (25 %), and dydrogesterone and hCG (17 %). Logistic regression showed that only dydrogesterone group had significantly lower CPR in comparison with vaginal progesterone (OR = 0.39; p = 0.03), while it was comparable between other three groups. There were no significant difference between four groups regarding to OPR and MR.
Conclusion
Vaginal progesterone provides appropriate LPS. Yet, combination of oral dydrogesterone and GnRH-α or hCG can be more suitable option compared to vaginal progesterone for LPS in women with vaginal irritation or discharge at a lower cost.
Similar content being viewed by others
References
Gardner DK, Weissman A, Howles CM, Shoham Z (2012) Textbook of assisted reproductive techniques. Clinical perspectives, vol 2, 4th edn. CRC Press, Florida
Eftekhar M, Rahsepar M, Rahmani E (2013) Effect of progesterone supplementation on natural frozen-thawed Embryo transfer cycles: a randomized controlled trial. Int J Fertil Steril. 7(1):13
Ashrafi M, Jahangiri N, Hassani F, Akhoond MR, Madani T (2011) The factors affecting the outcome of frozen–thawed embryo transfer cycle. Taiwan J Obstet Gynecol 50(2):159–164
Veleva Z, Orava M, Nuojua-Huttunen S, Tapanainen JS, Martikainen H (2013) Factors affecting the outcome of frozen–thawed embryo transfer. Hum Reprod 28(9):2425–2431
Lan VTN, Tuan P, Canh L, Tuong H, Howles C (2008) Progesterone supplementation during cryopreserved embryo transfer cycles: efficacy and convenience of two vaginal formulations. Reprod Biomed Online 17(3):318–323
Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R, Ghosh S (2005) Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study. J Steroid Biochem Mol Biol 97(5):416–420
Shapiro DB, Pappadakis JA, Ellsworth NM, Hait HI, Nagy ZP (2014) Progesterone replacement with vaginal gel versus im injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts. Hum Reprod 29(8):1706–1711
Ganesh A, Chakravorty N, Mukherjee R, Goswami S, Chaudhury K, Chakravarty B (2011) Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1373 women undergoing in vitro fertilization: a randomized clinical study. Fertil Steril 95(6):1961–1965
Salehpour S, Tamimi M, Saharkhiz N (2013) Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): a randomized clinical trial. Iran J Reprod Med 11(11):913
Patki A, Pawar VC (2007) Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone. Gynecol Endocrinol 23(S1):68–72
Guo W, Chen X, Ye D, He Y, Li P, Niu J et al (2013) Effects of oral dydrogesterone on clinical outcomes of frozen-thawed embryo transfer cycles; Nan fang yi ke da xue xue bao. J South Med Univ 33(6):861–865
van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M (2011) Luteal phase support for assisted reproduction cycles. The Cochrane Library, London
Gordon JD, DiMattina M, Reh A, Botes A, Celia G, Payson M (2013) Utilization and success rates of unstimulated in vitro fertilization in the United States: an analysis of the Society for Assisted Reproductive Technology database. Fertil Steril 100(2):392–395
Nawroth F, Ludwig M (2005) What is the ‘ideal’duration of progesterone supplementation before the transfer of cryopreserved–thawed embryos in estrogen/progesterone replacement protocols? Hum Reprod 20(5):1127–1134
Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Ross R (2008) Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony. Fertil Steril 89(1):20–26
Cercas R, Villas C, Pons I, Braña C, Fernandez-Shaw S (2012) Vitrification can modify embryo cleavage stage after warming. Should we change endometrial preparation? J Assist Reprod Genet 29(12):1363–1368
Lee VCY, Li RHW, Ng EHY, Yeung WSB, Ho PC (2013) Luteal phase support does not improve the clinical pregnancy rate of natural cycle frozen-thawed embryo transfer: a retrospective analysis. Eur J Obstet Gynecol Reprod Biol 169(1):50–53
Zhao Y, Brezina P, Hsu C-C, Garcia J, Brinsden PR, Wallach E (2011) In vitro fertilization: four decades of reflections and promises. Biochim Biophys Acta Gen Subj 1810(9):843–852
Bjuresten K, Landgren B-M, Hovatta O, Stavreus-Evers A (2011) Luteal phase progesterone increases live birth rate after frozen embryo transfer. Fertil Steril 95(2):534–537
Vaisbuch E, Leong M, Shoham Z (2012) Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey. Reprod Biomed Online 25(2):139–145
Kyrou D, Kolibianakis E, Fatemi H, Tarlatzi T, Devroey P, Tarlatzis B (2011) Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: a systematic review and meta-analysis. Hum Reprod Update 17(6):734–740
Pirard C, Donnez J, Loumaye E (2006) GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Hum Reprod 21(7):1894–1900
Tesarik J, Hazout A, Mendoza-Tesarik R, Mendoza N, Mendoza C (2006) Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist-and antagonist-treated ovarian stimulation cycles. Hum Reprod 21(10):2572–2579
Ata B, Yakin K, Balaban B, Urman B (2008) GnRH agonist protocol administration in the luteal phase in ICSI–ET cycles stimulated with the long GnRH agonistprotocol: a randomized, controlled double blind study. Hum Reprod 23(3):668–673
Reshef E, Lei Z, Rao CV, Pridham D, Chegini N, Luborsky J (1990) The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab 70(2):421–430
Fujimoto A, Osuga Y, Fujiwara T, Yano T, Tsutsumi O, Momoeda M et al (2002) Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles. J Assist Reprod Genet 19(12):550–554
Var T, Tonguc EA, Doğanay M, Gulerman C, Gungor T, Mollamahmutoglu L (2011) A comparison of the effects of three different luteal phase support protocols on in vitro fertilization outcomes: a randomized clinical trial. Fertil Steril 95(3):985–989
Bourdiec A, Bédard D, Rao C, Akoum A (2013) Human chorionic gonadotropin regulates endothelial cell responsiveness to interleukin 1 and amplifies the cytokine-mediated effect on cell proliferation, migration and the release of angiogenic factors. Am J Reprod Immunol 70(2):127–138
Cunningham FGLK, Bloom SL, Hauth JC, Rouse DJ, Spong CY (2010) Implantation, embryogenesis, and placental development: secretory or postovulatory endometrial phase. In: Cunningham FGLK, Bloom SL, Hauth JC, Rouse DJ, Spong CY (eds) Williams obstetrics. McGraw-Hill, New York, p 48
Kodaman PH, Taylor HS (2004) Hormonal regulation of implantation. Obstet Gynecol Clin North Am 31(4):745–766
van de Vijver A, Polyzos NP, Van Landuyt L, Mackens S, Stoop D, Camus M et al (2016) What is the optimal duration of progesterone administration before transferring a vitrified-warmed cleavage stage embryo? Randomized controlled trial. Hum Reprod 31(5):1097–1104
Casper RF, Yanushpolsky EH (2016) Optimal endometrial preparation for frozen embryo transfer cycles: window of implantation and progesterone support. Fertil Steril 105(4):867–872
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was funded by granny from vice chancellor of research of Shiraz University of Medical Sciences (Grant No. 1376-52-21).
Conflict of interest
None of the authors have any conflict of interest to declare regarding the manuscript.
Ethical approval
All procedures performed in the current study were in accordance with the ethical standards of the Shiraz University of Medical Sciences and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Zarei, A., Sohail, P., Parsanezhad, M.E. et al. Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles: a randomized clinical trial. Arch Gynecol Obstet 295, 239–246 (2017). https://doi.org/10.1007/s00404-016-4217-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-016-4217-4